» Articles » PMID: 1493844

Heating and Cooling of the Nitroglycerin Patch Application Area Modify the Plasma Level of Nitroglycerin

Overview
Specialty Pharmacology
Date 1992 Jan 1
PMID 1493844
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

19 healthy volunteers wore a nitroglycerin patch releasing 10 mg per 24 h for 2 h. Subsequently, the skin area surrounding the patch was exposed to 15 min of local heating with an infrared bulb (Group A, n = 10), or local cooling with an ice-pack (Group B, n = 9). The patch was protected by an insulating shield (Styrofoam). After 10 min of heating, the median (Walsh) plasma nitroglycerin level increased from 3.1 to 7.6 nmol.l-1. Body temperature remained constant. After 15 min of cooling the median plasma level had dropped from 2.1 to 1.4 nmol.l-1. The results demonstrate that changes in skin temperature may cause extensive short-term changes in the bioavailability of nitroglycerin. Presumably, a subcutaneous or cutaneous reservoir builds up during transdermal treatment, and changes in regional cutaneous blood flow affect the rate of drainage from the reservoir into the systemic circulation.

Citing Articles

In Vitro-In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature.

Thomas S, Hammell D, Hassan H, Stinchcomb A Pharm Res. 2023; 40(5):1249-1258.

PMID: 37095369 DOI: 10.1007/s11095-023-03487-z.


Local vasoregulative interventions impact drug concentrations in the skin after topical laser-assisted delivery.

Wenande E, Gundavarapu S, Tam J, Bhayana B, Thomas C, Farinelli W Lasers Surg Med. 2022; 54(10):1288-1297.

PMID: 35593006 PMC: 9675883. DOI: 10.1002/lsm.23558.


The Impact of Diet and Exercise on Drug Responses.

Niederberger E, Parnham M Int J Mol Sci. 2021; 22(14).

PMID: 34299312 PMC: 8304791. DOI: 10.3390/ijms22147692.


Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis.

La Count T, Zhang Q, Murawsky M, Hao J, Ghosh P, Dave K AAPS J. 2020; 22(4):82.

PMID: 32488395 PMC: 7644264. DOI: 10.1208/s12248-020-00457-w.


Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications.

LaCount T, Zhang Q, Hao J, Ghosh P, Raney S, Talattof A AAPS J. 2020; 22(3):70.

PMID: 32390069 PMC: 7644225. DOI: 10.1208/s12248-020-00451-2.


References
1.
Weber S, de Lauture D, Rey E, Darragon T, Severins J, Ditisheim A . The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine. Br J Clin Pharmacol. 1987; 23(1):103-5. PMC: 1386149. DOI: 10.1111/j.1365-2125.1987.tb03018.x. View

2.
Lindberg L, Tamura T, Oberg P . Photoplethysmography. Part 1. Comparison with laser Doppler flowmetry. Med Biol Eng Comput. 1991; 29(1):40-7. DOI: 10.1007/BF02446294. View

3.
Gumbleton M, Benet L . Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers. Br J Clin Pharmacol. 1991; 31(2):211-3. PMC: 1368399. DOI: 10.1111/j.1365-2125.1991.tb05521.x. View

4.
Barkve T, Langseth-Manrique K, Bredesen J, Gjesdal K . Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. Am Heart J. 1986; 112(3):537-41. DOI: 10.1016/0002-8703(86)90518-1. View

5.
McNiff E, Yacobi A, GOLDEN L, Goldfarb A, Fung H . Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci. 1981; 70(9):1054-8. DOI: 10.1002/jps.2600700923. View